Jean-Francois Aubry, PhD

Dr. Aubry is a director of research at Institut Langevin, CNRS, Paris and invited associate professor at the University of Virginia Department of Radiation Oncology since 2013. He is a member of the Focused Ultrasound Foundation’s Research Advisory Committee and the president of the International Society for Therapeutic Ultrasound (ISTU). He has received the Frederic Lizzi Early Career Award from ISTU and the bronze medal from the CNRS.

 
Alberto Bazzocchi, MD, PhD

Dr. Bazzocchi works as a consultant radiologist at the Rizzoli Orthopaedic Institute's department of Diagnostic and Interventional Radiology. Since 2015, he has been the external specialist-consultant in charge at the Romagna Scientific Institute for the Study and Treatment of Tumors (IRST – IRCCS, IRCCS, Scientific Research Hospital), focusing on high-intensity Focused Ultrasound (HIFU) and interventional radiology procedures.

 
Matthew Bucknor, MD

Dr. Bucknor is an Assistant Professor in the Musculoskeletal Imaging subspecialty section of the Department of Radiology and Biomedical Imaging at the University of California, San Francisco (UCSF) where he serves as Clinical Co-Director of the Focused Ultrasound program. His main clinical and research interest is developing new musculoskeletal applications of MR-guided focused ultrasound (MRgFUS), including new treatments of bone metastases, desmoid tumors, osteoid osteomas, and other focal musculoskeletal conditions. He leads several ongoing clinical trials of MRgFUS at UCSF and has received awards from the Radiological Society of North America and National Institutes of Health for his work. He is also interested in minimally invasive ultrasound, CT-guided interventions, and novel imaging techniques for evaluating bone and soft tissue tumors.

Kim Butts-Pauly, PhD

Dr. Butts-Pauly is a professor of radiology, and a professor of bioengineering and electrical engineering by courtesy, at Stanford University. Her research has evolved from magnetic resonance (MR)-guided interventions, to MR-guided focused ultrasound (MRgFUS), and to MRgFUS-based neuromodulation. She is the co-director of the Radiological Sciences Laboratory and director of the Center for Biomedical Imaging at Stanford.

Alexandre Carpentier, MD, PhD

Dr. Carpentier is an academic neurosurgeon specialized in performing brain tumor and epilepsy surgery at the Pitie-Salpetriere University Hospital, Assistance Publique Hopitaux de Paris. He is Professor of Neurosurgery and Medicine at Paris 6 Sorbonne University School of Medicine in Paris France. His recent work focuses on ultrasound-based treatments developing a miniature interstitial ultrasound device for tumor ablation and an implantable ultrasound device for blood-brain barrier opening and drug delivery. Both are promoted by CARTHERA, a university spin-off company that he founded in 2010.

Jin Woo Chang, MD, PhD

Dr. Chang is a Professor in the Department of Neurosurgery and the Director of the Brain Research Institute at Yonsei University College of Medicine, Seoul, Korea. His clinical work has included using focused ultrasound to treat movement disorders and pioneering research into treating psychiatric disorders like OCD and depression. He served as the honorary president of the 5th International Symposium on Focused Ultrasound in 2016.

Lili Chen, PhD

Dr. Chen is a Medical Physicist and Associate Professor in the Department of Radiation Oncology at Fox Chase Cancer Center, Philadelphia. Her research was focused on image guidance and assessment for radiation therapy, MR guided HIFU surgery, and pulsed HIFU enhancement of drug delivery for gene therapy and chemotherapy in combination with radiotherapy. She published over 60 peer-reviewed papers, 5 book chapters and 10 peer reviewed proceedings. She was a principal investigator on several research grants from US federal agencies and not-for-profit foundations. She also served as a grant reviewer for these agencies and other funding organizations. She served on several AAPM committees and task groups, and was elected an AAPM Fellow in 2013. She also served on scientific committees of several other professional societies including ACMP and ISMRM.    

Rees Cosgrove, MD, FRCSC

Dr. Cosgrove is the Director of Epilepsy and Functional Neurosurgery at Brigham and Women’s Hospital in Boston. He is also Director of the Neurosurgery Residency Training Program. As a leader in academic neurosurgery, he is a member of the executive committee of the World Society of Stereotactic and Functional Neurosurgery; past president of the American Society of Stereotactic and Functional Neurosurgery and an active member of the American Association of Neurosurgeons; the Congress of Neurological Surgeons; the American Academy of Neurological Surgery; and the Society of Neurological Surgeons. 

Patrick Dillon, MD

Dr. Dillion is Associate Professor of Medicine in Hematology and Oncology at the University of Virginia, where he specializes in the treatment of breast and skin cancers. His current research focuses on immune modulation for treatment of human cancers. He also leads clinical trials of chemotherapeutic agents for the treatment of breast cancer. He promotes cancer survivorship issues and takes an interest in early and late term side effects of cancer treatments.

Katherine Ferrara, PhD

Dr. Ferrara is a Distinguished Professor of Biomedical Engineering at UC Davis and the Director of the Center for Content Rich Evaluation of Therapeutic Efficacy (cCRETE). She is a member of the National Academy of Engineering and a fellow of the IEEE, American Association for the Advancement of Science, the Biomedical Engineering Society, the Acoustical Society of America and the American Institute of Medical and Biological Engineering. Her laboratory is known for early work in aspects of ultrasonics and has more recently expanded their focus to broadly investigate molecular imaging and drug delivery.

Joseph Frank, MD, MS

Dr. Frank is a tenured scientist at NIH whose research focus is directed towards improving cellular therapies for regenerative medicine and malignancy. His current interest is in investigating the ability of pulsed focused ultrasound to enhance cell homing and the mechanotransductive effects of ultrasound in tissues and diseases. 

Paul Fishman, MD, PhD

Dr. Fishman is Professor of Neurology, Pharmacology and Neurobiology at the University of Maryland School of Medicine, and Chief of Neurology for the VA Maryland Health Care System. With dual training in Neuroscience and Neurology his research interest is the translation of novel therapies for neurodegenerative diseases. He co-founded programs for Neurotoxin Therapeutics, Deep Brain Stimulation and is a founding member of FUS Center of Excellence at the University of Maryland. 

Nathan Fountain, MD

Dr. Fountain is Professor of Neurology and Director of the F.E. Dreifuss Comprehensive Epilepsy Program at the University of Virginia. His research includes studies of drugs and devices for epilepsy and evolution of seizure frequency, and he is PI of the ongoing Focused Ultrasound for Subcortical Epilepsy (FUSE) trial. He co-authored the first epilepsy quality measures which were subsequently adopted by Medicare and is President of the National Association of Epilepsy Centers and Co-chair of the Research Roundtable for Epilepsy. 

Dheeraj Gandhi, MBBS

Dr. Gandhi is Professor of Radiology, Neurology and Neurosurgery at University of Maryland School of Medicine. He directs the Interventional Neuroradiology Program and co-directs the Center of Metabolic Imaging and Therapeutics. His clinical and research interests focus on minimally invasive treatments for intracranial aneurysms and stroke as well as developing image-based direct targeting methods for focused ultrasound procedures.

Wladyslaw Gedroyc, MBBS, MRCP, FRCR

Dr. Gedroyc is a consultant radiologist at St Mary’s Hospital Imperial College healthcare NHS trust London. He is an acknowledged pioneer in MR-guided focused ultrasound and image guided therapy having been working in the FUS field for more than 16 years. He is the author of multiple papers on focused ultrasound of fibroids, bone, facet joints, liver, brain and drug activation utilizing focused ultrasound. 

Pejman Ghanouni, MD, PhD

Dr. Ghanouni is a Body MRI radiologist and an assistant professor in the Radiology, Neurosurgery and Urology departments at Stanford University. He has an impressive clinical reputation in focused ultrasound, and the majority of his clinical work has been for bone metastases, uterine fibroids, and essential tremor in adults. Also a pioneer in the pediatric arena, Dr. Ghanouni treats soft tissue tumors in children and teenagers and osteoid osteomas – benign but painful bone tumors. Ghanouni is the honorary president of the 6th International Symposium on Focused Ultrasound. 

Jürgen Götz, PhD

Professor Götz is Foundation Chair of Dementia Research and Director of the Clem Jones Centre for Ageing Dementia Research at the Queensland Brain Institute (University of Queensland, Australia). Götz is an internationally renowned expert in basic research on Alzheimer’s disease (AD). He generated the first tau transgenic mouse model with an early AD phenotype. He provided evidence for the amyloid cascade hypothesis and identified a novel function of tau in mediating Aβ toxicity via Fyn. Recently, he used scanning ultrasound to clear Aβ and tau in Alzheimer's mice which was associated with improved memory functions. 

Arik Hananel, MD, MBA, BsCS

Dr. Hananel is currently Co-Founder & CEO of FUSMobile. His former roles include: Medical and Scientific Director for the Focused Ultrasound Foundation, Insightec management, International Society for Therapeutic Ultrasound Board member, Journal of Therapeutic Ultrasound Co-Chief Executive Editor, and University of Virginia visiting professor. 

Joo Ha Hwang, MD, PhD

Dr. Hwang is a Professor of Medicine at Stanford University. He specializes in early detection of gastrointestinal malignancies including esophageal cancer, gastric (stomach) cancer, pancreatic cancer, bile duct cancer and colon cancer. He has been performing research in the field of focused ultrasound since 2000, primarily investigating the use of FUS to enhance drug delivery for the treatment of pancreatic cancer. He is also the Principle Investigator of a new Foundation-organized multinational registry for focused ultrasound treatment of pancreatic cancer.

Daniel Jeanmonod, MD

Dr. Jeanmonod is the head of the Center for Ultrasound Functional Neurosurgery (SoniModul AG, Solothurn, Switzerland), where patients suffering from Parkinson’s disease, essential tremor and neuropathic pain are treated regularly applying the MR-guided focused ultrasound technique. His interest and expertise are focused on the field of functional neurosurgery, with research accents on neuroanatomy and neurophysiology, and covering the treatment of chronic and therapy-resistant functional brain disorders including movement disorders, neuropathic pain and tinnitus, epilepsy and neuropsychiatric disorders. He also holds the titular professoral chair for functional neurosurgery at the University of Zürich.

Michael Kaplitt, MD, PhD

Dr. Kaplitt is Assistant Professor of Neurological Surgery at Weill Cornell Medicine, where he specializes in neurosurgical treatment of movement disorders, including Parkinson's disease, essential tremor and dystonia. His clinical activities focus upon using minimally invasive, stereotactic techniques for the treatment of functional disorders such as Parkinson's disease, essential tremor and epilepsy. He was the first in New York to use focused ultrasound to treat essential tremor. 

Tatiana Khokhlova, PhD

Dr. Khokhlova is a Research Assistant Professor at the Department of Medicine, University of Washington. Her research interests and expertise lie in physics of ultrasound wave propagation and the associated bioeffects, primarily in therapeutic applications of focused ultrasound. Dr. Khokhlova’s most recent work was targeted at the development of methods of soft tissue erosion and permeabilization by ultrasound-induced bubbles and the investigation of the resulting systemic effects, including immune response. She obtained her undergraduate and PhD degrees in physics from M.V. Lomonosov Moscow State University in Moscow, Russia, followed by post-doctoral training at Applied Physics Lab, University of Washington.

Vera Khohklova, PhD

Prof. Khokhlova is an Associate Professor at Moscow State University in Russia and a Principal Engineer at the Center for Industrial and Medical Ultrasound at the University of Washington. Her research interests are in the field of nonlinear acoustics, therapeutic ultrasound including metrology and bioeffects of high-intensity focused ultrasound fields, shock wave focusing, and modeling nonlinear wave propagation in inhomogeneous media. Prof. Khokhlova has served as a Member of the Executive Council of the Acoustical Society of America, a Member of the Board of the International Society for Therapeutic Ultrasound. She is also a Member of the Scientific Council on Acoustics of the Russian Academy of Sciences.

AeRang Kim, MD, PhD

Dr. Kim is a member of the solid tumor faculty at Children’s National Health System and an Assistant Professor of Pediatrics. She specializes in sarcomas and developmental therapeutics, and her research focuses on development of novel therapeutics for pediatric cancer including pre-clinical testing of novel agents, pharmacokinetic analysis, developing innovative methods for toxicity monitoring, and clinical trial design. She serves as the principal investigator of multiple early phase trials in pediatric oncology, sarcomas, and NF1 associated tumors.

Alexander L. Klibanov, PhD

Dr. Klibanov is an Associate Professor at Cardiovascular Division at University of Virginia (UVA) School of Medicine; he has joint appointments at UVA Biomedical Engineering and Radiology Departments. Prior to joining UVA, he held a research position in industry – since 1993 (Mallinckrodt, St. Louis, MO) where he worked on ultrasound contrast agents – and academic positions at the University of Pittsburgh, University of Tennessee, and Cardiology Research Center in Moscow. He is a graduate of Chemistry Department of Moscow State University (1979). His research interests are in the area of bioconjugate chemistry, molecular imaging, and targeted/triggered drug delivery systems, including ultrasound.

Vibhor Krishna, MD, ScM

Dr. Krishna is a neurosurgeon-scientist at The Ohio State University. He has an expertise in neuromodulation and functional neurosurgery. In his lab, he investigates both the imaging-based therapies (specifically focused ultrasound and image-guided deep brain stimulation) and imaging-guidance to improve patient outcomes after neuromodulation procedures. He has co-developed a tractography-based technique for improving the safety of focused ultrasound ablation in patients with essential tremor. He is also investigating the application of focused ultrasound for treatment resistant epilepsy and advanced Parkinson’s disease.

Cyril Lafon, PhD

Dr. Lafon is a research director at INSERM and heads the LabTAU in Lyon. His early research included developing interstitial HIFU probes and ultrasound-induced hemostasis and the development of tissue mimicking phantoms for HIFU applications. His recent research interests focus on modeling ultrasound wave propagation, development of ultrasonic therapeutic devices for thermal ablation or drug delivery.

Brian Lang, MD

Dr. Lang is currently the Clinical Professor and Division Chief of Endocrine Surgery, Department of Surgery, Queen Mary Hospital, Hong Kong. He is also the director for The Surgical Skill Training Program at the Department of Surgery, The University of Hong Kong. Dr. Lang has published more than 140 articles in peer-reviewed international journals. His clinical and research interests include thyroid carcinoma, thyroid nodules hyperparathyroidism, adrenal tumors, multiple endocrine neoplasia and neuroendocrine tumors. 

James Larner, MD

Dr. Larner is Professor and Chair of the University of Virginia (UVA) Department of Radiation Oncology, and Professor of Internal Medicine (Hematology/Oncology).  Additionally, he is Co-Medical Director of the UVA Focused Ultrasound Center and Co-Leader of the Genetics and Epigenetics Program of UVA’s Cancer Center. His clinical interests include focused ultrasound, neuro-oncology including gamma knife radiosurgery and thoracic oncology.  His NIH-funded laboratory focuses on DNA damage sensing pathways, DNA repair, and the interaction of DNA damage with the immune system.  

Suzanne LeBlang, MD

Dr. LeBlang is Co-Chief Medical Officer at the Focused Ultrasound Foundation. She has over 10 years of clinical experience performing focused ultrasound treatments on uterine fibroids and bone metastases and serves as Neuroradiologist and Medical Director of MR Guided Focused Ultrasound at the University MRI & Diagnostic Imaging Centers in Boca Raton, FL. She serves on the faculty at the University of Miami Medical School where she is the Radiology Clinical Coordinator for the 3rd year M.D./M.P.H. students, and she teaches at the Florida Atlantic University Schmidt College of Medicine.

Nir Lipsman, MD, PhD, FRCSC

Dr. Lipsman is a neurosurgeon and scientist at Sunnybrook Research Institute and Sunnybrook Health Sciences Center, and an Assistant Professor in the Department of Surgery at the University of Toronto. His PhD investigated novel neuromodulation strategies for brain-circuit disorders, and he went on to complete a clinical fellowship in Stereotactic and Functional Neurosurgery. He is currently the clinical director for Sunnybrook’s Focused Ultrasound Center.  

Nathan McDannold, PhD

Dr. McDannold is a Research Associate at Brigham and Women’s Hospital and an Associate Professor of Radiology at Harvard Medical School. His research has focused on brain applications, drug delivery and neurodegenerative diseases. A medical physicist, he has been a participant in the care of every focused ultrasound patient treated at BWH since 1996.

Chrit Moonen, PhD

Dr. Moonen is a professor at the Division of Imaging at the University Medical Center in Utrecht, the Netherlands. He has been President of the International Society of Magnetic Resonance in Medicine (2006), the Society for Molecular Imaging (2009), and European Society for Molecular Imaging (2016). He also received the European Magnetic Resonance Award in 2000. His recent work is mainly in MRI-guided Focused Ultrasound, image-guided drug delivery, and molecular and cellular imaging. 

Pierre Mourad, PhD

Dr. Mourad holds a Professorship at the University of Washington, affiliated with a variety of departments whose interests are defined by brain disorders (Neurosurgery) or have an interest in developing medical technology (Engineering and Mathematics; Bioengineering; Applied Physics Laboratory). His research and pedagogy target translational research and commercialization, in collaboration with medical doctors and engineers. Specifically, he brings physics – generally ultrasound – to the diagnosis and treatment of diseases or disorders of the brain. His experience stretches from in vitro studies through commercialization steps that include pre-clinical trials of devices that I have developed or have helped to develop.

Alessandro Napoli, MD, PhD

Dr. Napoli is a Professor of Radiology in the Department of Radiological, Oncology and Pathological Science at the Sapienza University of Rome where he is also head of the MR-Guided Focused Ultrasound Treatment Unit. He has served as president elect of the European Society of Focused Ultrasound Therapy and organized the first two European symposia on focused ultrasound.

Jill O'Donnell-Tormey, PhD

Dr. O’Donnell-Tormey is Chief Executive Officer and Director of Scientific Affairs of the Cancer Research Institute (CRI), a nonprofit organization that is the global leader in supporting and coordinating research aimed at harnessing the immune system’s power to conquer all cancers. Prior to joining CRI, she served as a research associate in the department of medicine at Cornell University Medical College and as a postdoctoral fellow in the laboratory of cellular physiology and immunology at The Rockefeller University.

Dennis L. Parker, PhD

Dr. Parker is Professor of Radiology and Biomedical Informatics and Director of the Utah Center for Advanced Imaging Research at the University of Utah. He is a medical physicist with over 40 years of experience in medical imaging research and image-guided therapies. Dr. Parker performed early experiments to test whether MRI could be used to measure temperature and in the early 1980s published the first papers showing that MRI could be used to create images of temperature. More recently, he has developed some novel and highly efficient methods for monitoring temperature and measuring tissue elasticity in the fully insonified 3D volume for brain and breast applications.

Richard J. Price, PhD

Dr. Price is Professor of Biomedical Engineering, Radiation Oncology, and Radiology and Medical Imaging at the University of Virginia (UVa). He is also Research Director of the UVa Focused Ultrasound Center. He has been studying ultrasound-targeted drug and gene delivery for more than 20 years and was amongst the first to observe that interactions between contrast agent microbubbles and ultrasound can open endothelial barriers for targeted nanoparticle delivery. His more recent work has involved treating Parkinson’s disease, gliomas, and brain metastases. Additionally, he is investigating the role for focused ultrasound and immunotherapy. 

Narendra Sanghvi

Mr. Sanghvi is Chief Scientific Officer of SonaCare Medical, LLC, co-founder of Focus Surgery Inc. (a subsidiary of SonaCare Medical), and a pioneer in the field of high intensity focused ultrasound (HIFU). He is the inventor and developer of the Sonablate® HIFU device for the treatment of prostate disease. He served at the Indiana University School of Medicine as an associate professor and senior research scientist in the Department of Physiology and Biophysics. Sanghvi worked with Prof. F. J. Fry and developed the first clinical ultrasound image guided HIFU device for the treatment of brain cancer in 1972.

David Shonka, Jr., MD

Dr. Shonka is a fellowship-trained head and neck endocrine and oncologic surgeon at the University of Virginia. He specializes in the surgical treatment of endocrine disorders of the head and neck, including thyroid cancer and hyperparathyroidism. 

Jonathan R. Sukovich, PhD 

Dr. Sukovich is an assistant research scientist at the University of Michigan, where he focuses on developing technologies and methods to advance and improve histotripsy therapies. His research interests include therapeutic applications of cavitation, embedded system platform development for controlling and monitoring histotripsy therapies, and the physics of high-energy cavitation phenomena in biological materials.

Claire Tempany, MD

Dr. Tempany is the Ferenc Jolesz MD Professor of Radiology at Harvard Medical School and Vice Chair of Research at the Department of Radiology at Brigham and Women’s Hospital. She is a diagnostic radiologist and an expert in prostate cancer, MR-imaging, and image-guided interventions. Her lab is dedicated to MR-imaging for detection, diagnosis, staging, treatment monitoring of prostate cancer and image-guided interventions. Since 2000, she has been an active investigator in multiple trials for clinical MR-guided focused ultrasound. 

Gail ter Haar, PhD

Dr. ter Haar is the head of therapeutic ultrasound at the Institute of Cancer Research. Her research interests center on understanding how ultrasound interacts with tissue, especially the physical mechanisms involved in producing bio-effects (primarily heating & acoustic cavitation), and harnessing these effects for therapeutic benefit. Most recently her research has concentrated on developing devices and protocols for ultrasound based treatments of cancer.  She is founding President of the International Society for Therapy Ultrasound (ISTU).

Joan Vidal-Jove, MD, PhD

Dr. Vidal-Jove leads the first Oncological FUS-HIFU Unit in Spain at the Hospital University Mutua Terrassa. He is also Director of Interventional Oncology at the Institute Khuab in Barcelona. He has developed his career in various institutions in the U.S. and Europe, both in the healthcare field, research in the pharmaceutical industry and public administration. He has performed more than 200 oncological cases with focused ultrasound, including pancreatic and liver tumors.

Bradford Wood, MD

Dr. Wood is the Director of the NIH Center for Interventional Oncology, where he directs a multi-disciplinary team that develops and translates devices, software, and navigation approaches for cancer patients via novel local and regional minimally-invasive image-guided therapies.

Graeme Woodworth, MD, FACS

Dr. Woodworth is an Associate Professor of Neurosurgery, Anatomy and Neurobiology, and Diagnostic Radiology and Nuclear Medicine at the University of Maryland School of Medicine. He is also Director of the Brain Tumor Treatment and Research Center at the University of Maryland, which includes the Focused Ultrasound Foundation Center of Excellence. He is a board-certified neurosurgeon and cares for patients with brain and spinal tumors. His research focuses on cross-disciplinary approaches to challenges in therapeutic delivery to invasive brain cancer using focused ultrasound-enhanced treatment strategies, nanotherapeutic drug formulations, and genetically engineered brain tumor models. He is leading efforts related to two clinical trials using MRI-guided FUS for blood-brain barrier disruption in patients with glioblastoma.

Seung-Schik Yoo, PhD, MBA

Dr. Yoo is an Associate Professor of Radiology at Harvard Medical School and a Director of Neuromodulation and Tissue Engineering Laboratory (NTEL), Brigham and Women's Hospital. He also serves as a faculty member of Mind Brain Behavior at Harvard University. He has done early pioneering works in developing real-time functional MR-imaging to interpret the human mind and applied the technology to interface the brain function with machines and computers. Later, he developed a new mode of non-invasive brain stimulation modality which utilizes the focused ultrasound waves to control regional neural functions, including the activity of the brain. He is primarily interested in advancing the technique for various neurotherapeutics, but also likes to seek out new ways to link thoughts/brain processes between individuals.